[1]
Atli, E., Kalkan, R., Mail, C. , Eker, D. , Demirci, U., Demir, S. , Yalcintepe, S., Kirkizlar, H.O. , Atli, E. , Gurkan, H. and Demir, A.M. 2021. THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies. Mediterranean Journal of Hematology and Infectious Diseases. 13, 1 (Jan. 2021), e2021013. DOI:https://doi.org/10.4084/mjhid.2021.013.